NanoVibronix (NAOV) Revenue & Revenue Breakdown
NanoVibronix Revenue Highlights
Latest Revenue (Y)
$2.28M
Latest Revenue (Q)
$376.00K
Main Geography (Y)
UNITED STATES
NanoVibronix Revenue by Period
NanoVibronix Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $2.28M | 203.59% |
2022-12-31 | $752.00K | -55.63% |
2021-12-31 | $1.70M | 172.07% |
2020-12-31 | $623.00K | 17.55% |
2019-12-31 | $530.00K | 66.67% |
2018-12-31 | $318.00K | 33.05% |
2017-12-31 | $239.00K | 4.37% |
2016-12-31 | $229.00K | 55.78% |
2015-12-31 | $147.00K | -27.59% |
2014-12-31 | $203.00K | -3.79% |
2013-12-31 | $211.00K | 27.11% |
2012-12-31 | $166.00K | 76.60% |
2011-12-31 | $94.00K | - |
NanoVibronix Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $376.00K | -53.98% |
2024-06-30 | $817.00K | -11.29% |
2024-03-31 | $921.00K | -21.75% |
2023-12-31 | $1.18M | 156.99% |
2023-09-30 | $458.00K | 55.78% |
2023-06-30 | $294.00K | -16.95% |
2023-03-31 | $354.00K | -447.06% |
2022-12-31 | $-102.00K | -205.15% |
2022-09-30 | $97.00K | -80.00% |
2022-06-30 | $485.00K | 78.31% |
2022-03-31 | $272.00K | -64.90% |
2021-12-31 | $775.00K | 55.31% |
2021-09-30 | $499.00K | 56.92% |
2021-06-30 | $318.00K | 208.74% |
2021-03-31 | $103.00K | 14.44% |
2020-12-31 | $90.00K | -40.00% |
2020-09-30 | $150.00K | -44.24% |
2020-06-30 | $269.00K | 135.96% |
2020-03-31 | $114.00K | 31.03% |
2019-12-31 | $87.00K | -13.86% |
2019-09-30 | $101.00K | -61.60% |
2019-06-30 | $263.00K | 232.91% |
2019-03-31 | $79.00K | 46.30% |
2018-12-31 | $54.00K | - |
2018-09-30 | $54.00K | -59.09% |
2018-06-30 | $132.00K | 71.43% |
2018-03-31 | $77.00K | 10.00% |
2017-12-31 | $70.00K | 7.69% |
2017-09-30 | $65.00K | 25.00% |
2017-06-30 | $52.00K | - |
2017-03-31 | $52.00K | 6.12% |
2016-12-31 | $49.00K | -19.67% |
2016-09-30 | $61.00K | -1.61% |
2016-06-30 | $62.00K | 8.77% |
2016-03-31 | $57.00K | 46.15% |
2015-12-31 | $39.00K | -2.50% |
2015-09-30 | $40.00K | 2.56% |
2015-06-30 | $39.00K | 34.48% |
2015-03-31 | $29.00K | -44.23% |
2014-12-31 | $52.00K | 108.00% |
2014-09-30 | $25.00K | -60.94% |
2014-06-30 | $64.00K | 3.23% |
2014-03-31 | $62.00K | 675.00% |
2013-12-31 | $8.00K | -84.00% |
2013-09-30 | $50.00K | 47.06% |
2013-03-31 | $34.00K | -40.35% |
2012-12-31 | $57.00K | 42.50% |
2012-09-30 | $40.00K | - |
NanoVibronix Revenue Breakdown
NanoVibronix Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
UNITED STATES | $2.16B | $710.00K | $1.63M | - | - |
AUSTRALIA | $19.00M | $9.00K | - | - | - |
Europe | $101.00M | $25.00K | $18.00K | $147.00K | $168.00K |
ISRAEL | $1.00M | $5.00K | - | - | - |
INDIA | - | $3.00K | - | - | - |
Other Country | - | $5.00K | - | - | - |
Other country | - | - | $45.00K | - | - |
United States | - | - | - | $467.00K | $331.00K |
Other | - | - | - | $5.00K | $5.00K |
Israel | - | - | - | $3.00K | $14.00K |
India | - | - | - | $1.00K | $12.00K |
Latest
Quarterly Revenue by Country
Country | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Mar 20 | Sep 19 | Jun 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UNITED STATES | $349.00K | $794.00K | $905.00M | $2.16B | $445.00K | $282.00K | $309.00K | $-118.00K | $90.00K | $476.00K | $231.00K | $753.00K | $490.00K | $292.00K | - | - | - | - | - | - |
Australia/New Zealand | $7.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Europe | $8.00K | $100.98M | $19.00K | $12.00K | $6.00K | $7.00K | $3.00K | $4.00K | $10.00K | $1.00K | $10.00K | $17.00K | $3.00K | - | $151.00K | - | - | - | - | - |
Other | $12.00K | $15.00K | $23.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
AUSTRALIA | - | $8.00K | $4.00M | $18.98M | $2.00K | $13.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Other Country | - | - | $12.00M | $11.00K | $12.00K | $12.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Asia | - | - | - | - | - | - | $1.00K | $1.00K | $9.00K | - | - | - | - | - | - | - | - | - | - | - |
NEW ZEALAND | - | - | - | - | - | - | - | - | $1.00K | $3.00K | $2.00K | $3.00K | $3.00K | - | - | - | - | - | - | - |
ISRAEL | - | - | - | - | - | - | - | - | - | - | - | $1.00K | $2.00K | $1.00K | - | - | - | - | - | - |
CANADA | - | - | - | - | - | - | - | - | - | - | - | - | - | $12.00K | - | - | - | - | - | - |
New Zealand | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $9.00K | - | - | - | - | - |
United States | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $92.00K | $76.00K | $130.00K | $110.00K | $101.00K | $90.00K |
Israel | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.00K | - | $1.00K | $1.00K | - | $12.00K |
India | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.00K | $2.00K | $8.00K | - | - |
Canada | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Canada 21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.00K |
Latest
NanoVibronix Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
RPID | Rapid Micro Biosystems | $22.52M | $7.60M |
HSCS | Heart Test Laboratories | $18.60M | - |
VVOS | Vivos Therapeutics | $13.80M | $3.86M |
NUWE | Nuwellis | $8.86M | $2.37M |
RSLS | ReShape Lifesciences | $8.68M | $2.29M |
SINT | Sintx | $2.63M | $799.00K |
NAOV | NanoVibronix | $2.28M | $376.00K |
TIVC | Tivic Health Systems | $1.18M | $126.00K |
BJDX | Bluejay Diagnostics | - | - |
BBLG | Bone Biologics | - | - |
BMRA | Biomerica | - | $1.81M |